Barbara Voith
Impact in
- Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
Papers in
-
- Atrial Fibrillation Management and Outcomes 4
- Surgery 3
- Lipoproteins and Cardiovascular Health 3
- Co-authors
- Michael Becka (5 shared papers)Dagmar Kubitza (5 shared papers)Michael Zuehlsdorf (4 shared papers)Georg Wensing (4 shared papers)Andrea N. Edginton (1 shared paper)Walter Schmitt (1 shared paper)Stefan Willmann (1 shared paper)Wolfgang Mueck (1 shared paper)
In The Last Decade
Barbara Voith
15 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Internal Medicine 919
- Cardiology and Cardiovascular Medicine 1.1k
- Hematology 230
- Pharmacology 114
- Pediatrics, Perinatology and Child Health 130
Countries citing papers authored by Barbara Voith
This map shows the geographic impact of Barbara Voith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Voith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Voith more than expected).
Fields of papers citing papers by Barbara Voith
This network shows the impact of papers produced by Barbara Voith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Voith. The network helps show where Barbara Voith may publish in the future.
Co-authors
The 25 scholars most cited alongside Barbara Voith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor Hit paper breakdown → | 2005 | 512 |
| 2 | Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939—an oral, direct Factor Xa inhibitor—after multiple dosing in healthy male subjects Hit paper breakdown → | 2005 | 507 |
| 3 | 2006 | 171 | |
| 4 | 2007 | 142 | |
| 5 | 2008 | 78 | |
| 6 | 1998 | 28 | |
| 7 | 2013 | 25 | |
| 8 | Multiple dose escalation study investigating the pharmacodynamics, safety, and pharmacokinetics of BAY 59-7939 an oral, direct Factor Xa inhibitor in healthy male subjects | 2003 | 19 |
| 9 | 2000 | 10 | |
| 10 | 2000 | 7 | |
| 11 | 2000 | 7 | |
| 12 | 2001 | 4 | |
| 13 | Safety, tolerability, and pharmacokinetics following multiple oral doses of faropenem daloxate and impact on fecal and oral flora | 2000 | 3 |
| 14 | No evidence of active metabolites of faropenem | 2001 | 1 |
| 15 | 1995 | 1 |
About Barbara Voith
Barbara Voith is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Pharmacology, Pediatrics, Perinatology and Child Health and Internal Medicine, having authored 15 papers that have together received 1.5k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Lipoproteins and Cardiovascular Health (3 papers), Pharmacological Effects and Toxicity Studies (2 papers), Analytical Methods in Pharmaceuticals (2 papers), Computational Drug Discovery Methods (2 papers) and Blood Coagulation and Thrombosis Mechanisms (2 papers). The work is most often cited by research in Internal Medicine (919 citations), Cardiology and Cardiovascular Medicine (1.1k citations), Hematology (230 citations), Pharmacology (114 citations) and Pediatrics, Perinatology and Child Health (130 citations). Barbara Voith has collaborated with scholars based in Germany and Hong Kong. Frequent co-authors include Michael Becka, Dagmar Kubitza, Michael Zuehlsdorf, Georg Wensing, Andrea N. Edginton, Walter Schmitt, Stefan Willmann, Wolfgang Mueck, Burkhard Fugmann and Johannes Nagelschmitz. Their work appears in journals such as Clinical Pharmacokinetics, Journal of Pharmaceutical and Biomedical Analysis, Clinical Pharmacology & Therapeutics, British Journal of Clinical Pharmacology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.